Clinical trial · Interventional
Primary Palliative Care for Patients With Advanced Hematologic Malignancies
SHARE - Supportive Care Management for Patients With Hematologic Cancers by Registered Nurses
NCT02992171CI-TRIAL-00044806completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study seeks to develop and pilot-test an oncology nurse-led care management intervention to meet the primary palliative care needs of patients with advanced hematologic malignancies.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| care management by oncology nurses | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- care management by oncology nurses
- description
- The intervention employs a care management approach to facilitate provision of primary palliative care within existing oncology clinic structures. The intervention is deployed through a series of nurse-led encounters occurring before or after regularly-scheduled oncology clinic visits.
- interventionNames
- Behavioral: care management by oncology nurses
Primary outcomes (1)
- measure
- Successful enrollment of 30 patient-caregiver pairs
- timeFrame
- Baseline to 3 months
Secondary outcomes (7)
- measure
- Consent-to-approach rate
- timeFrame
- Baseline to 3 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Participants will be (1) patients with advanced hematologic malignancies receiving care at a participating clinic; (2) their caregivers; (3) participating clinicians. Patient: Inclusion Criteria: * adults (≥ 21 years old) * Refractory or Recurrent hematologic cancer: lymphoma, leukemia, myeloma, amyloidosis (secondary manifestation myeloma \& AL Amyloidosis), and CML (CML can only be accelerated or blast phase) * planning to receive ongoing care from a participating oncologist and willing to be seen at least monthly. Exclusion criteria: * chronic myeloid leukemia (CML) OTHER THAN accelerated or blast phase * unable to read and respond to questions in English * lacks decision-making capacity, as determined by the patient's oncologist * unable to complete baseline interview Caregiver Inclusion Criteria: * adults (≥ 21 years old) * family member or friend of an eligible patient Exclusion criteria: * unable to read and respond to questions in English * unable to complete the baseline interview (patients will be asked to select as caregiver the person who is most likely to accompany them to visits or help with their care should they need it) Eligible clinicians will be oncology nurses and oncologists practicing at participating clinics.
References
Publications (0)
Data not yet available
No reference posted for this study.